R. Kirk Huntsman

2020

In 2020, R. Kirk Huntsman earned a total compensation of $455.3K as Chief Executive Officer principal executive officer at Vivos Therapeutics, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$177,847
Salary$251,784
Other$25,705
Total$455,336

Huntsman received $251.8K in salary, accounting for 55% of the total pay in 2020.

Huntsman also received $177.8K in non-equity incentive plan and $25.7K in other compensation.

Rankings

In 2020, R. Kirk Huntsman's compensation ranked 11,264th out of 13,090 executives tracked by ExecPay. In other words, Huntsman earned more than 13.9% of executives.

ClassificationRankingPercentile
All
11,264
out of 13,090
14th
Division
Manufacturing
4,823
out of 5,620
14th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
649
out of 799
19th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
408
out of 495
18th
Industry
Surgical and Medical Instruments and Apparatus
265
out of 313
15th
Source: SEC filing on June 29, 2021.

Huntsman's colleagues

We found two more compensation records of executives who worked with R. Kirk Huntsman at Vivos Therapeutics in 2020.

2020

G Singh

Vivos Therapeutics

Chief Medical Officer

2020

Bradford Amman

Vivos Therapeutics

Chief Financial Officer

News

You may also like